Emerson Electric (EMR) Tops Q2 EPS by 1c; offers guidance

Emerson Electric (NYSE: EMR) reported Q2 EPS of $1.54, $0.01 better than the analyst estimate of $1.53. Revenue for the quarter came in at $4.56 billion versus the consensus estimate of $4.6 billion.

GUIDANCE:

Emerson Electric sees Q3 2026 EPS of $1.65-$1.70, versus the consensus of $1.68.

Emerson Electric sees FY2026 EPS of $6.45-$6.55, versus the consensus of $6.49.

For earnings history and earnings-related data on Emerson Electric (EMR) click here.

You May Also Be Interested In

• Summit Therapeutics (SMMT) Reiterated at Market Outperform by Citizens
• Akamai Technologies (AKAM) PT Raised to $225 at Guggenheim
• Acadia Pharmaceuticals (ACAD) PT Lowered to $33 at Citizens on Ph2 Miss for Remlifanserin